231 related articles for article (PubMed ID: 33583597)
1. The Role of Systemic Therapy in Advanced Cutaneous Squamous Cell Carcinoma.
McMullen CP; Ow TJ
Otolaryngol Clin North Am; 2021 Apr; 54(2):343-355. PubMed ID: 33583597
[TBL] [Abstract][Full Text] [Related]
2. Favorable efficacy of S-1 treatment for locoregionally advanced cutaneous squamous cell carcinoma in the head and neck region.
Izumi T; Teramoto Y; Kamimura A; Doi R; Takai S; Mori T; Koizumi S; Kawahara Y; Aitake U; Lei X; Inomata N; Inafuku K; Nakamura Y
J Dermatol; 2024 Feb; 51(2):271-279. PubMed ID: 38009848
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy in head and neck cancer: aiming at EXTREME precision.
Szturz P; Vermorken JB
BMC Med; 2017 Jun; 15(1):110. PubMed ID: 28571578
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant Immunotherapy for Head and Neck Squamous Cell Carcinoma: Expecting Its Application in Temporal Bone Squamous Cell Carcinoma.
Shi MW; Huang J; Sun Y
Curr Med Sci; 2023 Apr; 43(2):213-222. PubMed ID: 36971976
[TBL] [Abstract][Full Text] [Related]
5. FDA Approval Summary: Pembrolizumab for the Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma with Disease Progression on or After Platinum-Containing Chemotherapy.
Larkins E; Blumenthal GM; Yuan W; He K; Sridhara R; Subramaniam S; Zhao H; Liu C; Yu J; Goldberg KB; McKee AE; Keegan P; Pazdur R
Oncologist; 2017 Jul; 22(7):873-878. PubMed ID: 28533473
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of Treatment With Neoadjuvant Cemiplimab for Patients With Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck: Secondary Analysis of a Phase 2 Clinical Trial.
Ferrarotto R; Nagarajan P; Maronge JM; Johnson JM; Rosenthal DI; Myers JN; Gross ND
JAMA Otolaryngol Head Neck Surg; 2023 Sep; 149(9):847-849. PubMed ID: 37535378
[TBL] [Abstract][Full Text] [Related]
7. Current status of systemic therapy for recurrent and/or metastatic squamous cell carcinoma of the head and neck.
Jacob LA; Chaudhuri T; Lakshmaiah KC; Babu KG; Dasappa L; Babu M; Rudresha AH; Lokesh KN; Rajeev LK
Indian J Cancer; 2016; 53(4):471-477. PubMed ID: 28485332
[TBL] [Abstract][Full Text] [Related]
8. Prolonged Response to Pembrolizumab in Spindle Cell Squamous Cell Carcinoma Metastatic to the Central Nervous System.
Liu Y; Fitzgerald B; Perry E; Pathak A; Chao HH
J Investig Med High Impact Case Rep; 2019; 7():2324709619850216. PubMed ID: 31132886
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxic and targeted systemic therapy in patients with advanced cutaneous squamous cell carcinoma in the head and neck.
Tam S; Gajera M; Luo X; Glisson BS; Ferrarotto R; Johnson FM; Mott FE; Gillison ML; Lu C; Le X; Blumenschein GR; Wong MK; Rosenthal DI; Nagarajan P; El-Naggar AK; Midgen MR; Weber RS; Myers JN; Gross ND
Head Neck; 2021 May; 43(5):1592-1603. PubMed ID: 33522021
[TBL] [Abstract][Full Text] [Related]
10. Real world data of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinoma.
Baggi A; Quaglino P; Rubatto M; Depenni R; Guida M; Ascierto PA; Trojaniello C; Queirolo P; Saponara M; Peris K; Spagnolo F; Bianchi L; De Galitiis F; Potenza MC; Proietti I; Marconcini R; Botticelli A; Barbieri V; Licitra L; Alfieri S; Ficorella C; Cortellini A; Fargnoli MC; Troiani T; Tondulli L; Bossi P
Eur J Cancer; 2021 Nov; 157():250-258. PubMed ID: 34536948
[TBL] [Abstract][Full Text] [Related]
11. Comparative efficacy of cemiplimab versus other systemic treatments for advanced cutaneous squamous cell carcinoma.
Keeping S; Xu Y; Chen CI; Cope S; Mojebi A; Kuznik A; Konidaris G; Ayers D; Sasane M; Allen R; Huynh TM; Popoff E; Freeman M; Andria ML; Fury MG; Singh K; Stockfleth E; Challapalli A; Schmults CD
Future Oncol; 2021 Feb; 17(5):611-627. PubMed ID: 33052055
[No Abstract] [Full Text] [Related]
12. Cemiplimab for the treatment of advanced cutaneous squamous cell carcinoma.
Hernández-Guerrero T; Doger B; Moreno V
Drugs Today (Barc); 2019 Aug; 55(8):485-494. PubMed ID: 31461085
[TBL] [Abstract][Full Text] [Related]
13. Therapy of advanced squamous cell carcinoma of the skin.
Bejar C; Maubec E
Curr Treat Options Oncol; 2014 Jun; 15(2):302-20. PubMed ID: 24643778
[TBL] [Abstract][Full Text] [Related]
14. Toxicities of systemic agents in squamous cell carcinoma of the head and neck (SCCHN); A new perspective in the era of immunotherapy.
Saba NF; Mody MD; Tan ES; Gill HS; Rinaldo A; Takes RP; Strojan P; Hartl DM; Vermorken JB; Haigentz M; Ferlito A
Crit Rev Oncol Hematol; 2017 Jul; 115():50-58. PubMed ID: 28602169
[TBL] [Abstract][Full Text] [Related]
15. High-Risk Cutaneous Squamous Cell Carcinoma of the Head and Neck: A Clinical Review.
Yan F; Tillman BN; Nijhawan RI; Srivastava D; Sher DJ; Avkshtol V; Homsi J; Bishop JA; Wynings EM; Lee R; Myers LL; Day AT
Ann Surg Oncol; 2021 Dec; 28(13):9009-9030. PubMed ID: 34195900
[TBL] [Abstract][Full Text] [Related]
16. Pembrolizumab and its use in the treatment of recurrent or metastatic head and neck cancer.
Sheth S; Weiss J
Future Oncol; 2018 Jul; 14(16):1547-1558. PubMed ID: 29464975
[TBL] [Abstract][Full Text] [Related]
17. Cemiplimab for the treatment of advanced cutaneous squamous cell carcinoma.
Villani A; Ocampo-Garza SS; Potestio L; Fabbrocini G; Ocampo-Candiani J; Ocampo-Garza J; Scalvenzi M
Expert Opin Drug Saf; 2022 Jan; 21(1):21-29. PubMed ID: 34644510
[TBL] [Abstract][Full Text] [Related]
18. Update on the anti-programmed cell death-1 receptor antibodies in advanced cutaneous squamous-cell carcinoma.
Benzaquen M
Dermatol Ther; 2020 May; 33(3):e13325. PubMed ID: 32208547
[TBL] [Abstract][Full Text] [Related]
19. Update in the treatment of non-melanoma skin cancers: the use of PD-1 inhibitors in basal cell carcinoma and cutaneous squamous-cell carcinoma.
Ascierto PA; Schadendorf D
J Immunother Cancer; 2022 Dec; 10(12):. PubMed ID: 36455990
[TBL] [Abstract][Full Text] [Related]
20. Cemiplimab-rwlc as first and only treatment for advanced cutaneous squamous cell carcinoma.
Ahmed SR; Petersen E; Patel R; Migden MR
Expert Rev Clin Pharmacol; 2019 Oct; 12(10):947-951. PubMed ID: 31524530
[No Abstract] [Full Text] [Related]
[Next] [New Search]